trial · primary record
Nipocalimab
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 201 |
| Primary completion | 2028-07-11 |
| Primary endpoint | Stage B: Time to First Occurrence of a Relapse Event |
| Registry ID | NCT05327114 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:57.364Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05327114
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nipocalimab · compound